by Hisham S. Ayoub, DMD BioHealth Investor For the first time in seven years a new therapy for Chronic Lymphocytic Leukemia (CLL) has been cleared in the U.S. by the FDA. Biotech firm Cephalon's (CEPH) TREANDA (bendamustine hydrochloride) was...
(click article title to read more...)
